Secukinumab dosing every 2 weeks demonstrated superior efficacy compared with dosing every 4 weeks in patients with psoriasis weighing 90 kg or more: results of a randomized controlled trial-论文-万方医学网

首页> > Secukinumab dosing every 2 weeks demonstrated superior efficacy compared with dosing every 4 weeks in patients with psoriasis weighing 90 kg or more: results of a randomized controlled trial

Secukinumab dosing every 2 weeks demonstrated superior efficacy compared with dosing every 4 weeks in patients with psoriasis weighing 90 kg or more: results of a randomized controlled trial

导出原文传递

翻译打印收藏纠错

第一作者： Augustin, Matthias

作者： Augustin, Matthias ^[1] ; Reich, Kristian ^[2] ; Yamauchi, Paul ^[3] ; Pinter, Andreas ^[4] ; Bagel, Jerry ^[5] ; Dahale, Swapnil ^[6] ; You, Ruquan ^[7] ; Bruin, Gerard ^[8] ; Djimopoulos, Jimena ; Paguet, Bertrand ; Charef, Pascal ; Patekar, Manmath ; Keefe, Deborah

作者单位： Inst Hlth Serv Res Dermatol & Nursing IVDP,Univ Med Ctr Hamburg Eppendorf UKE ^[1] Dermatol Inst & Skin Care Ctr ^[2] Dept Dermatol Venereol & Allergol,Goethe Univ Frankfurt ^[3] Psoriasis Treatment Ctr Cent New Jersey ^[4] IQVIA ^[5] China Novartis Inst BioMed Res ^[6] Novartis Inst Biomed Res ^[7] Novartis Pharmaceut ^[8]

关键词 BODY-MASS INDEX PLAQUE PSORIASIS DOUBLE-BLIND OBESITY

发布时间 2022-07-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Secukinumab dosing every 2 weeks demonstrated superior efficacy compared with dosing every 4 weeks in patients with psoriasis weighing 90 kg or more: results of a randomized controlled trial

相似文献

同项目论文

相关期刊

检索历史 清除

Secukinumab dosing every 2 weeks demonstrated superior efficacy compared with dosing every 4 weeks in patients with psoriasis weighing 90 kg or more: results of a randomized controlled trial

相似文献

同项目论文

相关期刊

检索历史清除